Australia's most trusted
source of pharma news
Friday, 05 December 2025
Posted 14 February 2025 AM
Another patent extension has been ruled invalid, paving the way for generics to challenge a $50 million market.
Justice Kylie Downes ruled in the Federal Court that a patent extension covering Abilify Maintena, sponsored by Lundbeck in Australia, was wrongly granted. The extension meant the patent had an expiry date of 25 July 2029.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.